Individual Immune Cell and Cytokine Profiles Impact Platelet-Rich Plasma Composition : [Preprint]

Objective: Platelet-rich plasma (PRP) is increasingly popular to treat musculoskeletal diseases, including tendinopathies and osteoarthritis (OA). To date, it remains unclear to which extent PRP compositions are determined by the immune profile of individuals or by the preparation method. To investigate this, we compared leukocyte and cytokine distributions of different PRP products to donor blood samples.

Design: For each of three PRP preparations (ACP®, Angel™, and nSTRIDE® APS), products were derived using blood samples from twelve healthy donors. The cellular composition of PRP products was analyzed by flow cytometry using DURAClone antibody panels (DURAClone IM Phenotyping Basic and DURAClone IM T Cell Subsets). The MESO QuickPlex SQ 120 system was used to assess cytokine profiles (V-PLEX Proinflammatory Panel 1 Human Kit, Meso Scale Discovery).

Results: All three PRP products showed elevated portions of leukocytes compared to baseline levels in donor blood (p < 0.0001). Further, the pro-inflammatory cytokines IFN-γ (p = 0.039) and TNF-α (p = 0.013) were significantly increased in nSTRIDE® APS samples compared to donor blood and other PRP products. The characteristics of all other cytokines and immune cells from the donor blood, including pro-inflammatory T cell subsets, were maintained in all PRP products.

Conclusions: Individuals with elevated levels of cells with pro-inflammatory properties maintain these in the final PRP products. The concentration of pro-inflammatory cytokines strongly varies between PRP products. These observations may help to unravel the previously described heterogeneous response to PRP in OA therapy. Both the individual’s immune profile and the concentration method appear to impact the final PRP product.


Citation style:
Could not load citation form.

Access Statistic

Last 12 Month:


Use and reproduction: